Drug intelligence / Profile preview

Lepisor

Development stage
Unknown
Lead developer
Soria Natural
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Lepisor is a botanical drug product developed by the Spanish company Soria Natural for the treatment of mild to moderate benign prostatic hyperplasia (BPH) in adult males. It is a combination herbal preparation containing extracts of *Orthosiphon stamineus* (Java tea) and *Lepidium latifolium* (perennial pepperweed). The product is classified as a phytotherapeutic medicine and has been evaluated in Phase 3 clinical trials in Spain. Although its precise molecular mechanisms are not fully defined, it is believed to act through pathways common to herbal BPH treatments, such as the inhibition of 5α-reductase, anti-inflammatory effects, and the relaxation of smooth muscle in the prostate gland.

Brand names
Lepisor
Other names
Orthosiphon stamineus + Lepidium latifolium
02

Targets

SRD5A (Steroid 5-alpha-reductase)

Beyond the preview

Go deeper on Lepisor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lepisor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call